Erectile Dysfunction: Causes, Impact & Evidence-Based Treatments
Erectile dysfunction (ED) is the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity. It affects ~30–50% of men 40–70, increasing with age and comorbidity.
Pathophysiology (Simplified)
Erection = neurovascular event: Sexual stimulation → NO release → cGMP ↑ → smooth muscle relaxation → arterial inflow ↑ + venous occlusion (tunica albuginea) → rigidity. **Any disruption** along this pathway causes ED.
Major Etiologies
| Category | Examples | Mechanism |
|---|---|---|
| Vascular (70%) | Atherosclerosis, HTN, dyslipidemia, smoking, PAD | Impaired arterial inflow / veno-occlusive dysfunction |
| Neurogenic | Diabetic neuropathy, spinal cord injury, MS, Parkinson’s, pelvic surgery (RP), radiation | Interrupted efferent/afferent signals |
| Hormonal | Low T, hyperprolactinemia, thyroid disorders | ↓ Libido, impaired NO synthase |
| Medication-induced | SSRIs, β-blockers, thiazides, 5-ARIs, antiandrogens, opioids | Multiple mechanisms |
| Psychogenic | Performance anxiety, depression, relationship conflict, pornography-associated | Cortical inhibition of spinal centers |
| Structural | Peyronie’s disease, pelvic trauma, fibrosis | Mechanical impairment |
Impact Beyond Sexual Function
- Cardiovascular sentinel: ED precedes CAD/MI by 3–5 years (endothelial dysfunction shared).
- Psychosocial: Depression, anxiety, low self-esteem, relationship strain.
- Quality of life: Comparable to angina, COPD in utility studies.
Stepwise Management
- Lifestyle: Weight loss, exercise, smoking cessation, Mediterranean diet, limit alcohol.
- Oral PDE5 inhibitors: Sildenafil, tadalafil, vardenafil, avanafil — 60–70% response. Contraindicated with nitrates.
- Second-line: Vacuum erection device, intraurethral alprostadil (MUSE), penile injections (alprostadil, bimix, trimix).
- Third-line: Penile prosthesis (inflatable 3-piece — gold standard for durability/satisfaction).
- Testosterone: Only if hypogonadal (symptoms + low T on 2 AM draws).
- Psychosexual therapy: CBT, sensate focus, couples counseling.
When to See a Urologist
- ED >3 months, or earlier if cardiovascular risk factors present.
- Desire for non-oral options.
- Complex comorbidities (post-RP, Peyronie’s, hypogonadism).
ED is a **window into vascular health**. Evaluation should include lipid panel, HbA1c, BP, testosterone, and cardiovascular risk assessment.
Urinary Disorders - Related Articles
- UTI Diagnosis: Why Urine Testing Is Essential and Blood Tests Are Not Enough
- Understanding and Managing Enuresis: Causes & Treatment
- Frequent Urination: Medications & Treatment Options
- 12 Common Causes of Frequent Urination: From UTIs and Diabetes to Medications and Aging
- Understanding Male Anatomy and When to Seek Medical Advice
- Effective Hangover Relief: Tips & Recovery Strategies
- Enablex Side Effects: Understanding Potential Risks & Symptoms
